Mereo BioPharma Group plc
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 61.47 | -100% | -10.76 | -100% |
| P/S |
|
152.33 | 33.58 | 353.64% |
|
|
| P/BV |
|
30.14 | 4.79 | 528.99% |
|
|
| P/FCF |
|
-7.08 | 60.06 | -111.78% |
|
|
| Ev/Ebitda |
|
-61.45 | -17.26 | 255.99% |
|
|
| Ev/S |
|
147.19 | 22.49 | 554.56% |
|
|
| Ev/FCF |
|
-68.3 | 67.63 | -200.99% |
|
|
| E/P |
|
-0.1932 | 0.0168 | -1247.12% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-239.54 | 4.5 | -5427.34% | 3626.72 | -106.6% |
| ROE |
|
-58.31 | 9.39 | -720.85% |
|
|
| ROA |
|
-44.31 | 0.1519 | -29266.09% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-294.66 | -25.64 | 1049.19% |
|
|
| ROCE |
|
-49.5 | 15.19 | -425.95% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.2107 | -3.68 | -94.27% | -0.3384 | -37.75% |
| Nеt Debt/Ebitda |
|
2.15 | -4.07 | -152.84% |
|
|
| Debt/Ratio |
|
0.0759 | 0.199 | -61.87% |
|
|
| Debt/Equity |
|
0.0632 | 1.67 | -96.21% |
|
|
| Debt/Net Income |
|
-0.1712 | 10.34 | -101.66% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5399 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2331 | -100% |
|
|
| Average dividend growth |
|
0 | 1.07 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4916 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.32 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5399 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
-6635.95 | 76.2 | -8808.6% | ||
| Growth impulse Ebitda in 5 years |
|
-8.06 | 44.75 | -118.01% | ||
| Growth impulse Net Income in 5 years |
|
12.08 | -15.36 | -178.65% | ||
| Growth impulse FCF in 5 years |
|
-37.84 | -9.39 | 302.98% | ||
| Growth impulse EPS in 5 years |
|
-97.71 | -84.03 | 16.28% |
IP Score
2.27/10
